From ROC analysis, we found that 80%, 65.7%, and 54.2% of the patients with recurrent HCC exhibited highly expressed cyclin B1, Sec62, and Birc3, respectively. The gene discussed is CCNB1; the disease is hepatocellular carcinoma.